IMV Inc Sustainability Reports
IMV Inc. was a clinical-stage biopharmaceutical company that developed a portfolio of immune-educating therapies. It pioneered immunotherapies based on a proprietary drug delivery platform targeting cancer and infectious diseases.
Sector: Manufacturing
Country: Canada
Exchange: OTC Markets
FIGI: BBG001T08Q81
1 reports from 2020 to 2020
Company Profile
IMV Inc. was a clinical-stage biopharmaceutical company that developed a portfolio of immune-educating therapies. It pioneered immunotherapies based on a proprietary drug delivery platform targeting cancer and infectious diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
